e-learning
resources
ERS Research Seminars
2005
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Disruption of the HIF-1 pathway in cancer cells
L. Poellinger (Stockholm, Sweden)
Source:
Research Seminar 2005 - Adaptations to Hypoxia
Number:
4
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Poellinger (Stockholm, Sweden). Disruption of the HIF-1 pathway in cancer cells. Research Seminar 2005 - Adaptations to Hypoxia
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Inhibition of hypoxia-induced phenotype alterations through epithelial-mesenchymal transition (EMT) in lung cancer by gene modulation of phosphorylation sites in tumor suppressor PTEN
Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics
Year: 2011
The effect of compensatory induction of various PTEN mutants against TGFbeta-induced translocation of beta-catenin in lung cancer cells
Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases
Year: 2013
Hypoxia induces IL-1β and TNF-α expressionin of U937 cells involving PKCα/RAF-1/MAPK/NF-κB pathway
Source: Eur Respir J 2005; 26: Suppl. 49, 102s
Year: 2005
Micro RNA-21 Targeting PI3K/PTEN/Akt signaling axis regulates multiple biological functions in human lung cancer
Source: International Congress 2018 – Lung cancer: from the bench to the bedside
Year: 2018
AMPK signalling regulates Nrf2 localization and activity via sirtuins in a monocytic cell line
Source: Annual Congress 2011 - Recent developments in COPD
Year: 2011
Late Breaking Abstract - Membrane bile acid receptor contributes to the proliferation of lung cancer cells induced by lung fibroblast-tumor cells interaction though TLR4/NF-kB signaling pathway
Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench
Year: 2017
Depletion of STAT6 suppresses lung cancer progression through regulating M2-macrophage polarization
Source: International Congress 2018 – Lung cancer: from the bench to the bedside
Year: 2018
KPNB1-mediated PD-L1 nuclear translocation promotes non-small cell lung cancer cell proliferation via the Gas6/MerTK signalling pathway
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Year: 2020
BMP-Smad1 target gene Wnt inhibitory factor 1 (WIF1) coordinates BMP and Wnt signaling activities in regulating lung development in vivo
Source: Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases
Year: 2010
WNT5A antagonizes canonical WNT/beta-catenin signaling in lung epithelial cells
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013
GSK-3 inhibition suppresses lung cancer cell survival, metastasis and proliferation through down-regulation the phosphorylation sites of CAP1
Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench
Year: 2017
Caspase recruitment domain containing protein 9 suppresses non-small cell lung cancer proliferation and invasion via inhibiting MAPK/p38 pathway
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020
Inhibition of proliferation of lung cancer cells by CD40 signaling through tumor necrosis factor I
Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology
Year: 2008
p38 MAPK/MSK1/CREB signal pathway involves in transforming growth factor-β-induced heme oxygenase-1 expression in human lung epithelial cells
Source: Eur Respir J 2007; 30: Suppl. 51, 544s
Year: 2007
Activation of NRF2 is responsible for the overexpression of peroxiredoxin and sulphiredoxin in human lung cancer
Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Year: 2009
Overexpression of LincR-PICALM promotes lung cancer proliferation and metastasis by miR-199a-3p suppression and cis- regulation
Source: International Congress 2019 – Novel molecular pathways in lung cancer and COPD
Year: 2019
MicroRNA-101 inhibits lung cancer growth and invasion through regulation of EZH2
Source: Annual Congress 2010 - Pathology of lung cancer
Year: 2010
PP222 – Forkhead Box F1 as a mediator of Wnt signaling in human lung endothelial cells
Source: ERS Lung Science Conference 2021
Year: 2021
Suppression of HIF-1a dependent gene regulation by the tumour suppressor gene PTEN in pulmonary cells
Source: Eur Respir J 2001; 18: Suppl. 33, 17s
Year: 2001
Involvement of NFkB activation and c-JUN phosphorylation in bronchial epithelial cells by CD-40-CD40L pathway
Source: Eur Respir J 2002; 20: Suppl. 38, 573s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept